查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2003035

心血管超音波診斷設備市場：全球市場按產品類型、影像技術、應用和最終用戶分類的預測—2026-2032年

Cardiovascular Ultrasound System Market by Product Type, Imaging Technology, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 190 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，心血管超音波診斷設備市場價值將達到 20.1 億美元，到 2026 年將成長至 21.7 億美元，到 2032 年將達到 34.2 億美元，複合年成長率為 7.88%。

主要市場統計數據
基準年 2025 20.1億美元
預計年份：2026年 21.7億美元
預測年份：2032年 34.2億美元
複合年成長率 (%) 7.88%

心血管超音波系統一直是現代心臟醫學的基石，它將診斷的準確性與臨床操作支援相結合。換能器技術的進步、影像處理演算法的改進以及系統結構的小型化，使得心血管超音波系統的臨床應用範圍從三級醫療機構擴展到了門診。目前，臨床醫生期望這些系統不僅能提供清晰的結構影像，還能提供可靠的功能數據，例如利用多普勒模式進行血流動力學評估以及高階組織表徵。

醫療領域的需求正朝著能夠與電子健康記錄遠端醫療整合、支援遠距醫療工作流程並能在臨床環境中實現快速決策的設備方向發展。因此，製造商們正在努力平衡高階成像功能與提升易用性之間的關係，以減少操作者之間的差異。由此，產品線不斷擴展，涵蓋了滿足全面成像需求的推車式平台、具有靈活部署選項的可攜式以及用於快速篩檢和床邊評估的手持式設備。本文概述了後續分析的框架，重點闡述了技術、臨床應用和醫療服務模式如何共同推動現代醫學中心血管超音波的發展。

人工智慧成像、設備小型化和互通性要求如何從根本上改變心血管超音波的採用和採購？

心血管影像領域正經歷一場變革，主要得益於電腦輔助成像、小型化和工作流程整合的整合。人工智慧 (AI) 和機器學習正日益融入影像擷取和解讀流程，從而提高影像的可重複性並減輕操作人員的認知負擔。同時，隨著診斷工作流程向分散式醫療機構轉移，對能夠在臨床環境中進行分診和隨訪並保持診斷準確性的手持式和可攜式設備的需求也日益成長。

評估近期美國關稅措施對設備採購、供應彈性和價格趨勢的多方面營運和採購影響。

近期貿易政策的發展，特別是已宣布的2025年關稅措施，正對心血管超音波診斷設備的供應鏈、採購流程和定價策略造成多方面的壓力。某些電子元件和成品醫療設備進口關稅的提高可能會推高依賴跨境採購的製造商的整體成本，促使他們重新評估供應商所在地和合約條款。為此，一些製造商可能會加快零件供應商多元化，或探索近岸外包方案，以降低關稅波動帶來的風險。

將產品外形規格、成像方式、臨床應用和最終用戶環境與設備選擇和市場定位連結起來的詳細細分分析。

產品類型（推車式、手持式和可攜式系統）的差異會影響其採用理由、臨床應用情境和整體成本考量。推車式平台通常用於滿足全面的診斷和介入工作流程，其中高級成像和配件整合至關重要。可攜式和手持式設備則滿足移動性和床邊快速評估的需求，從而擴大了其在門診和急診醫學領域的應用範圍。這些外形規格的差異與服務和培訓要求、生命週期管理方法以及升級管道密切相關。

美洲、歐洲、中東和非洲以及亞太地區的需求趨勢和部署管道將影響部署策略和服務模式。

區域趨勢受美洲、歐洲、中東和非洲以及亞太地區醫療基礎設施成熟度、報銷機制和臨床部署模式差異的影響。在美洲，一體化醫療體系和完善的門診網路推動了對高性能推車式系統和可適應不同臨床環境的多功能可攜式設備的需求。該地區的監管管道和採購實踐強調循證部署和長期服務夥伴關係。

競爭動態和策略夥伴關係透過影像效能、軟體生態系統和生命週期服務交付來塑造產品差異化。

競爭格局的特點是既有成熟的醫療設備製造商，也有敏捷的技術驅動型新興參與企業，它們都致力於透過影像效能、軟體生態系統和服務網路來打造差異化價值。成熟的製造商通常利用其豐富的產品系列來滿足醫院和大規模診斷中心的需求，提供整合了成像模式、臨床工作流程工具和長期維護合約的整合解決方案。同時，新興參與企業和技術主導公司則強調便攜性、雲端分析和簡化的使用者體驗，以吸引門診和照護現場情境。

在不斷變化的醫療保健環境中，製造商和供應商需要切實可行的策略措施來增強產品適應性、供應鏈韌性和長期客戶價值。

產業領導企業應優先考慮能夠使醫療設備的功能與不斷變化的臨床工作流程和採購實際情況相符的產品組合策略。投資於支援分階段升級的模組化架構，可以降低部署門檻並延長產品生命週期，使更多終端用戶能夠獲得先進的成像功能。同時，增強與電子健康記錄和遠端醫療平台的互通性，可以提高臨床價值，並支援整合到多站點醫療保健網路中。

高度透明的調查方法，結合對臨床醫生的訪談、技術規格以及對法規和指南的審查，為可操作的策略見解奠定了基礎。

本分析整合了對關鍵相關人員的訪談、同行評審的臨床文獻、設備技術規格以及實地研究的採購實踐，從而整體情況了心血管超音波領域。主要資訊來源包括對臨床醫生、生物醫學工程師、採購負責人和產品經理的結構化訪談，以了解實際應用案例和營運重點。此外，還開展了專注於技術藍圖、監管公告和最新臨床指南的二次研究，以闡明推動和阻礙技術普及的因素。

對創新、融入臨床工作流程和籌資策略如何協調一致以確保心血管超音波系統的成功實施進行綜合分析。

心血管超音波系統正處於轉折點，技術進步、醫療服務模式的轉變以及政策變化相互交織，重塑採購和臨床實踐。將強大的影像功能與最佳化工作流程的軟體和服務模式相結合的設備，被認為最能滿足醫院、診斷中心和門診機構多樣化的臨床需求。可攜式和手持式系統的興起擴大了應用範圍，同時也提高了人們對互通性、廠商支援和臨床性能檢驗的期望。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 工業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：心血管超音波診斷設備市場：依產品類型分類

  • 購物車類型
  • 手持式
  • 可攜式的

第9章：心血管超音波診斷設備市場：依影像技術分類

  • 2D
  • 3D/4D
  • 多普勒
    • 彩色多普勒
    • 連續波多普勒
    • 動力多普勒
    • 脈衝多普勒
  • 組織和諧

第10章：心血管超音波診斷設備市場：依應用領域分類

  • 成人心臟病學
  • 兒童循環系統
  • 血管影像
    • 動脈
    • 靜脈

第11章：心血管超音波診斷設備市場：依最終用戶分類

  • 門診治療
  • 心臟中心
  • 診斷中心
  • 醫院
    • 私人的
    • 民眾

第12章：心血管超音波診斷設備市場：按地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章：心血管超音波診斷設備市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 心血管超音波診斷設備市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章：美國心血管超音波診斷設備市場

第16章：中國心血管超音波診斷設備市場

第17章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • BK Medical Holding Company, Inc.
  • BMV MEDTECH GROUP CO., LTD.
  • CANON MEDICAL SYSTEMS CORPORATION
  • Carestream Health
  • CHISON Medical Technologies Co., Ltd.
  • Clarius Mobile Health Corp.
  • ContextVision AB
  • ESAOTE SPA
  • FUJIFILM France SAS
  • GE HealthCare
  • Healcerion Co., Ltd.
  • Hitachi Healthcare Americas
  • Koninklijke Philips NV
  • Player Name
  • Samsung Electronics Co., Ltd.
  • Shantou Institute of Ultrasonic Instruments Co., Ltd.
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • Siemens Healthcare Private Limited
  • SonoScape Medical Corp.
  • Supersonic Imagine
  • TELEMED MEDICAL SYSTEMS srl
  • TERATECH CORPORATION
Product Code: MRR-957C47F94CC9

The Cardiovascular Ultrasound System Market was valued at USD 2.01 billion in 2025 and is projected to grow to USD 2.17 billion in 2026, with a CAGR of 7.88%, reaching USD 3.42 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 2.01 billion
Estimated Year [2026] USD 2.17 billion
Forecast Year [2032] USD 3.42 billion
CAGR (%) 7.88%

Cardiovascular ultrasound systems remain foundational to contemporary cardiac care, combining diagnostic precision with procedural support across clinical settings. Advances in transducer technology, enhanced image processing algorithms, and increasingly compact system architectures have broadened clinical use cases from tertiary hospitals to ambulatory care clinics. Clinicians now expect systems to deliver not only clear structural imaging but also robust functional data such as hemodynamic assessment via Doppler modes and advanced tissue characterization.

The clinical community's demand profile is shifting toward devices that integrate seamlessly with electronic health records, support telemedicine workflows, and enable rapid point-of-care decision-making. Consequently, manufacturers are balancing the need for high-end imaging capabilities with usability improvements that reduce operator variability. As a result, the product landscape spans cart based platforms for comprehensive imaging needs, portable options for flexible deployment, and handheld devices aimed at rapid screening and bedside assessments. This introduction frames the subsequent analysis by highlighting how technology, clinical adoption, and care delivery models jointly drive the evolution of cardiovascular ultrasound in contemporary healthcare.

How AI-enabled imaging, device miniaturization, and interoperability demands are catalyzing a fundamental transformation in cardiovascular ultrasound deployment and procurement

The cardiovascular imaging landscape is undergoing transformative shifts driven by convergence of computational imaging, miniaturization, and workflow integration. Artificial intelligence and machine learning are increasingly embedded into image acquisition and interpretation pipelines, enhancing reproducibility and reducing the cognitive load on operators. In parallel, the migration of diagnostic workflows toward decentralized care settings has elevated demand for handheld and portable form factors that preserve diagnostic fidelity while enabling point-of-care triage and follow-up.

Another notable shift is the prioritization of interoperability; hospitals and ambulatory centers increasingly require devices that integrate with digital health infrastructures and support remote consultation. Imaging technology diversification-spanning advanced two-dimensional imaging, volumetric 3D/4D modalities, and multiple Doppler techniques-has expanded clinical capabilities, enabling more nuanced assessments of valvular function, myocardial mechanics, and vascular pathology. As clinicians adopt these capabilities, procurement strategies are shifting from single-vendor purchases to ecosystem-focused investments that emphasize lifecycle service, software updates, and analytics subscriptions. These transformative trends are recalibrating competitive dynamics and redefining value propositions across the industry.

Assessing the multifaceted operational and procurement implications of recent United States tariff measures on device sourcing, supply resilience, and pricing dynamics

Recent trade policy developments, particularly tariff measures announced in 2025, introduce multifaceted pressure points across supply chains, procurement practices, and pricing strategies for cardiovascular ultrasound systems. Increased import levies on certain electronic components and finished medical devices can elevate landed costs for manufacturers that rely on cross-border sourcing, prompting re-evaluation of supplier footprints and contractual terms. In response, some manufacturers may accelerate diversification of component suppliers or seek nearshoring options to mitigate exposure to tariff volatility.

Clinicians and health systems may experience procurement frictions as distributors adjust pricing and inventory policies to reflect altered cost structures. Delays in component availability could influence production schedules, contributing to longer lead times for advanced cart based systems that require complex assemblies. Conversely, tariffs may incentivize investment in domestic manufacturing capacity where feasible, leading to longer-term shifts in regional supply resilience. Importantly, the cumulative impact is context-dependent, varying by device form factor and the composition of electronic and mechanical subsystems. Strategic responses from manufacturers and purchasers-focusing on contractual flexibility, inventory management, and supplier redundancy-will determine how effectively organizations absorb and adapt to these tariff-driven headwinds.

In-depth segmentation analysis linking product form factors, imaging modalities, clinical applications, and end-user settings to device selection and market positioning

Product type distinctions-spanning cart based, handheld, and portable systems-shape acquisition rationale, clinical use cases, and total cost considerations. Cart based platforms typically serve comprehensive diagnostic and interventional workflows where advanced imaging and accessory integration are paramount. Portable and handheld devices address mobility and rapid bedside assessment needs, expanding access in ambulatory settings and emergency care. These form factor variations correlate with differing service and training requirements, lifecycle management approaches, and upgrade pathways.

Imaging technology segmentation-encompassing 2D, 3D/4D, Doppler, and tissue harmonic capabilities-further differentiates device utility. Doppler modalities, including color Doppler, continuous wave Doppler, power Doppler, and pulsed wave Doppler, enable nuanced hemodynamic evaluations that are essential for valvular assessment and vascular flow analysis. Applications range across adult cardiology, pediatric cardiology, and vascular imaging, with the latter subdividing into arterial and venous assessments that each impose distinct image resolution and frequency demands. End users span ambulatory care sites, cardiac centers, diagnostic centers, and hospitals, where private and public hospital settings often follow divergent procurement cycles and budgetary constraints. Integrating these segmentation lenses provides a comprehensive view of how clinical requirements, operational environments, and technology choices intersect to inform product positioning and go-to-market strategies.

Regional demand profiles and adoption pathways across the Americas, Europe Middle East & Africa, and Asia-Pacific that influence deployment strategies and service models

Regional dynamics are shaped by differences in healthcare infrastructure maturity, reimbursement frameworks, and clinical adoption patterns across the Americas, Europe, Middle East & Africa, and Asia-Pacific. In the Americas, integrated health systems and robust outpatient networks drive demand for both high-performance cart based systems and versatile portable units that can support diverse practice settings. Regulatory pathways and procurement behaviors in this region emphasize evidence-based adoption and long-term service partnerships.

Across Europe, Middle East & Africa, the trajectory is heterogeneous; advanced tertiary centers in certain economies prioritize cutting-edge imaging technologies, while resource-constrained markets emphasize cost-effective and ruggedized equipment. Reimbursement and procurement policies vary significantly, influencing the pace of technology diffusion. In the Asia-Pacific region, rapid clinical capacity expansion, investment in point-of-care infrastructure, and growing adoption of compact imaging solutions are notable trends. Manufacturers seeking regional scale must tailor go-to-market approaches to address local training needs, service expectations, and regulatory intricacies, while leveraging partnerships to accelerate clinical validation and deployment.

Competitive dynamics and strategic alliances shaping product differentiation through imaging performance, software ecosystems, and lifecycle service offerings

The competitive landscape is characterized by incumbent medical device firms and agile technology entrants that pursue differentiated value through imaging performance, software ecosystems, and service networks. Established manufacturers typically leverage broad product portfolios to meet the needs of hospitals and large diagnostic centers, offering integrated solutions that bundle imaging modalities with clinical workflow tools and long-term maintenance agreements. Concurrently, newer entrants and technology-focused companies emphasize portability, cloud-enabled analytics, and streamlined user experiences that appeal to ambulatory and point-of-care settings.

Partnerships and strategic collaborations between imaging specialists, semiconductor suppliers, and software developers are shaping innovation cycles. These alliances enable rapid incorporation of advanced signal processing, AI-driven analytics, and improved transducer designs into commercial products. In addition, aftermarket services-spanning training, remote diagnostics, and predictive maintenance-have emerged as critical differentiators, affecting purchasing decisions and vendor loyalty. Competitive dynamics will increasingly revolve around the ability to provide integrated, upgradeable platforms that balance image quality with usability and lifecycle support.

Practical strategic moves for manufacturers and providers to enhance product adaptability, supply chain resilience, and long-term customer value in evolving care settings

Industry leaders should prioritize a portfolio approach that aligns device capabilities with evolving clinical workflows and procurement realities. Investing in modular architectures that allow staged upgrades can reduce barriers to adoption and extend product lifecycles, making advanced imaging features accessible to a broader set of end users. Simultaneously, strengthening interoperability with electronic health records and telemedicine platforms will amplify clinical value and support integration into multi-site care networks.

Manufacturers and distributors must also strengthen supply chain resilience by diversifying supplier bases and exploring nearshoring where cost-effective, thereby mitigating exposure to tariff-related disruptions. Expanding service offerings-such as remote calibration, operator training, and subscription-based analytics-can create recurring revenue streams and deepen customer relationships. Finally, targeted clinical validation studies that demonstrate workflow efficiency gains and diagnostic impact will be essential to support uptake among hospital procurement committees and ambulatory care networks. These strategic moves will position industry players to capture demand across both centralized and decentralized care settings.

Transparent methodology integrating clinician interviews, technical specifications, and regulatory and guideline reviews to underpin actionable strategic insights

This analysis synthesizes primary stakeholder interviews, peer-reviewed clinical literature, device technical specifications, and observed procurement practices to construct a robust view of the cardiovascular ultrasound landscape. Primary inputs include structured interviews with clinicians, biomedical engineers, procurement officers, and product managers to capture real-world use cases and operational priorities. Secondary research focused on technology roadmaps, regulatory announcements, and clinical guideline updates to contextualize adoption drivers and barriers.

Data validation involved triangulating qualitative insights with product release information and publicly available device documentation. The methodology emphasized transparency in source attribution and reproducibility of analytic approaches. Where uncertainty or divergence emerged among sources, the report highlights differing viewpoints and outlines implications for strategic decision-making. This methodological rigor ensures that findings reflect both the technical contours of imaging technologies and the practical realities of clinical deployment and organizational procurement.

Synthesis of how innovation, clinical workflow integration, and procurement strategy must align to drive successful adoption of cardiovascular ultrasound systems

Cardiovascular ultrasound systems are at an inflection point where technological advances, changing care delivery models, and policy shifts intersect to reshape procurement and clinical practice. Devices that combine robust imaging modalities with workflow-enhancing software and service models will be best positioned to meet diverse clinical needs across hospitals, diagnostic centers, and ambulatory settings. The rise of portable and handheld systems expands access but also raises expectations for interoperability, operator support, and validated clinical performance.

Navigating tariff pressures and supply chain uncertainties requires proactive sourcing strategies and flexible commercial terms. Meanwhile, clinical adoption will depend on clear demonstrations of diagnostic utility and integration with care pathways. Organizations that align device strategy with clinical workflows, invest in operator training, and adopt modular purchasing approaches will realize the greatest operational and patient care benefits. In sum, success in this evolving environment depends on balancing innovation with pragmatic deployment and long-term service commitments.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Cardiovascular Ultrasound System Market, by Product Type

  • 8.1. Cart Based
  • 8.2. Handheld
  • 8.3. Portable

9. Cardiovascular Ultrasound System Market, by Imaging Technology

  • 9.1. 2D
  • 9.2. 3D/4D
  • 9.3. Doppler
    • 9.3.1. Color Doppler
    • 9.3.2. Continuous Wave Doppler
    • 9.3.3. Power Doppler
    • 9.3.4. Pulsed Wave Doppler
  • 9.4. Tissue Harmonic

10. Cardiovascular Ultrasound System Market, by Application

  • 10.1. Adult Cardiology
  • 10.2. Pediatric Cardiology
  • 10.3. Vascular Imaging
    • 10.3.1. Arterial
    • 10.3.2. Venous

11. Cardiovascular Ultrasound System Market, by End User

  • 11.1. Ambulatory Care
  • 11.2. Cardiac Centers
  • 11.3. Diagnostic Centers
  • 11.4. Hospitals
    • 11.4.1. Private
    • 11.4.2. Public

12. Cardiovascular Ultrasound System Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Cardiovascular Ultrasound System Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Cardiovascular Ultrasound System Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Cardiovascular Ultrasound System Market

16. China Cardiovascular Ultrasound System Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. BK Medical Holding Company, Inc.
  • 17.6. BMV MEDTECH GROUP CO., LTD.
  • 17.7. CANON MEDICAL SYSTEMS CORPORATION
  • 17.8. Carestream Health
  • 17.9. CHISON Medical Technologies Co., Ltd.
  • 17.10. Clarius Mobile Health Corp.
  • 17.11. ContextVision AB
  • 17.12. ESAOTE SPA
  • 17.13. FUJIFILM France S.A.S.
  • 17.14. GE HealthCare
  • 17.15. Healcerion Co., Ltd.
  • 17.16. Hitachi Healthcare Americas
  • 17.17. Koninklijke Philips N.V.
  • 17.18. Player Name
  • 17.19. Samsung Electronics Co., Ltd.
  • 17.20. Shantou Institute of Ultrasonic Instruments Co., Ltd.
  • 17.21. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • 17.22. Siemens Healthcare Private Limited
  • 17.23. SonoScape Medical Corp.
  • 17.24. Supersonic Imagine
  • 17.25. TELEMED MEDICAL SYSTEMS s.r.l.
  • 17.26. TERATECH CORPORATION

LIST OF FIGURES

  • FIGURE 1. GLOBAL CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL CARDIOVASCULAR ULTRASOUND SYSTEM MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY IMAGING TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY CART BASED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY CART BASED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY CART BASED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY HANDHELD, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY HANDHELD, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY HANDHELD, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY PORTABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY PORTABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY PORTABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY 2D, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY 2D, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY 2D, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY 3D/4D, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY 3D/4D, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY 3D/4D, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY DOPPLER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY DOPPLER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY DOPPLER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY DOPPLER, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY COLOR DOPPLER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY COLOR DOPPLER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY COLOR DOPPLER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY CONTINUOUS WAVE DOPPLER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY CONTINUOUS WAVE DOPPLER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY CONTINUOUS WAVE DOPPLER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY POWER DOPPLER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY POWER DOPPLER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY POWER DOPPLER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY PULSED WAVE DOPPLER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY PULSED WAVE DOPPLER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY PULSED WAVE DOPPLER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY TISSUE HARMONIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY TISSUE HARMONIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY TISSUE HARMONIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY ADULT CARDIOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY ADULT CARDIOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY ADULT CARDIOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY PEDIATRIC CARDIOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY PEDIATRIC CARDIOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY PEDIATRIC CARDIOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY VASCULAR IMAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY VASCULAR IMAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY VASCULAR IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY VASCULAR IMAGING, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY ARTERIAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY ARTERIAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY ARTERIAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY VENOUS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY VENOUS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY VENOUS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY AMBULATORY CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY AMBULATORY CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY AMBULATORY CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY CARDIAC CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY CARDIAC CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY CARDIAC CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY DIAGNOSTIC CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY DIAGNOSTIC CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY PRIVATE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY PRIVATE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY PRIVATE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY PUBLIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY PUBLIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY PUBLIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. AMERICAS CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 77. AMERICAS CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 78. AMERICAS CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 79. AMERICAS CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY DOPPLER, 2018-2032 (USD MILLION)
  • TABLE 80. AMERICAS CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 81. AMERICAS CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY VASCULAR IMAGING, 2018-2032 (USD MILLION)
  • TABLE 82. AMERICAS CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 83. AMERICAS CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 84. NORTH AMERICA CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. NORTH AMERICA CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 86. NORTH AMERICA CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 87. NORTH AMERICA CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY DOPPLER, 2018-2032 (USD MILLION)
  • TABLE 88. NORTH AMERICA CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 89. NORTH AMERICA CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY VASCULAR IMAGING, 2018-2032 (USD MILLION)
  • TABLE 90. NORTH AMERICA CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 91. NORTH AMERICA CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 92. LATIN AMERICA CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. LATIN AMERICA CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 94. LATIN AMERICA CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 95. LATIN AMERICA CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY DOPPLER, 2018-2032 (USD MILLION)
  • TABLE 96. LATIN AMERICA CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 97. LATIN AMERICA CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY VASCULAR IMAGING, 2018-2032 (USD MILLION)
  • TABLE 98. LATIN AMERICA CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 99. LATIN AMERICA CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 100. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY DOPPLER, 2018-2032 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY VASCULAR IMAGING, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 108. EUROPE CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. EUROPE CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 110. EUROPE CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 111. EUROPE CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY DOPPLER, 2018-2032 (USD MILLION)
  • TABLE 112. EUROPE CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 113. EUROPE CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY VASCULAR IMAGING, 2018-2032 (USD MILLION)
  • TABLE 114. EUROPE CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 115. EUROPE CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 116. MIDDLE EAST CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 117. MIDDLE EAST CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 118. MIDDLE EAST CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 119. MIDDLE EAST CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY DOPPLER, 2018-2032 (USD MILLION)
  • TABLE 120. MIDDLE EAST CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 121. MIDDLE EAST CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY VASCULAR IMAGING, 2018-2032 (USD MILLION)
  • TABLE 122. MIDDLE EAST CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 123. MIDDLE EAST CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 124. AFRICA CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 125. AFRICA CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 126. AFRICA CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 127. AFRICA CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY DOPPLER, 2018-2032 (USD MILLION)
  • TABLE 128. AFRICA CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 129. AFRICA CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY VASCULAR IMAGING, 2018-2032 (USD MILLION)
  • TABLE 130. AFRICA CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 131. AFRICA CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 132. ASIA-PACIFIC CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 133. ASIA-PACIFIC CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 134. ASIA-PACIFIC CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 135. ASIA-PACIFIC CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY DOPPLER, 2018-2032 (USD MILLION)
  • TABLE 136. ASIA-PACIFIC CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 137. ASIA-PACIFIC CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY VASCULAR IMAGING, 2018-2032 (USD MILLION)
  • TABLE 138. ASIA-PACIFIC CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 139. ASIA-PACIFIC CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 140. GLOBAL CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 141. ASEAN CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 142. ASEAN CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 143. ASEAN CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 144. ASEAN CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY DOPPLER, 2018-2032 (USD MILLION)
  • TABLE 145. ASEAN CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 146. ASEAN CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY VASCULAR IMAGING, 2018-2032 (USD MILLION)
  • TABLE 147. ASEAN CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 148. ASEAN CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 149. GCC CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 150. GCC CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 151. GCC CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 152. GCC CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY DOPPLER, 2018-2032 (USD MILLION)
  • TABLE 153. GCC CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 154. GCC CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY VASCULAR IMAGING, 2018-2032 (USD MILLION)
  • TABLE 155. GCC CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 156. GCC CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPEAN UNION CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPEAN UNION CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 159. EUROPEAN UNION CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 160. EUROPEAN UNION CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY DOPPLER, 2018-2032 (USD MILLION)
  • TABLE 161. EUROPEAN UNION CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 162. EUROPEAN UNION CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY VASCULAR IMAGING, 2018-2032 (USD MILLION)
  • TABLE 163. EUROPEAN UNION CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 164. EUROPEAN UNION CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 165. BRICS CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 166. BRICS CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 167. BRICS CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 168. BRICS CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY DOPPLER, 2018-2032 (USD MILLION)
  • TABLE 169. BRICS CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 170. BRICS CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY VASCULAR IMAGING, 2018-2032 (USD MILLION)
  • TABLE 171. BRICS CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 172. BRICS CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 173. G7 CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 174. G7 CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 175. G7 CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 176. G7 CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY DOPPLER, 2018-2032 (USD MILLION)
  • TABLE 177. G7 CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 178. G7 CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY VASCULAR IMAGING, 2018-2032 (USD MILLION)
  • TABLE 179. G7 CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 180. G7 CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 181. NATO CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 182. NATO CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 183. NATO CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 184. NATO CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY DOPPLER, 2018-2032 (USD MILLION)
  • TABLE 185. NATO CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 186. NATO CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY VASCULAR IMAGING, 2018-2032 (USD MILLION)
  • TABLE 187. NATO CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 188. NATO CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 189. GLOBAL CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 190. UNITED STATES CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 191. UNITED STATES CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 192. UNITED STATES CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 193. UNITED STATES CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY DOPPLER, 2018-2032 (USD MILLION)
  • TABLE 194. UNITED STATES CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 195. UNITED STATES CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY VASCULAR IMAGING, 2018-2032 (USD MILLION)
  • TABLE 196. UNITED STATES CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 197. UNITED STATES CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 198. CHINA CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 199. CHINA CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 200. CHINA CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 201. CHINA CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY DOPPLER, 2018-2032 (USD MILLION)
  • TABLE 202. CHINA CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 203. CHINA CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY VASCULAR IMAGING, 2018-2032 (USD MILLION)
  • TABLE 204. CHINA CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 205. CHINA CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)